(dp0
S'values'
p1
(dp2
V
p3
F0.108
sV70-6
p4
F0.001
sV72-7
p5
F0.001
sV380-4
p6
F0.001
sV1577-1588
p7
F0.001
sV10-10 ST  - CSM2004 best platform-
p8
F0.001
sV290-293
p9
F0.001
sV2077-86
p10
F0.001
sV290-296
p11
F0.001
sV249-50
p12
F0.001
sV1024-1025
p13
F0.001
sV761-762
p14
F0.001
sV42-55
p15
F0.001
sV714-9
p16
F0.001
sV239-244 6p
p17
F0.001
sV722-7
p18
F0.001
sVCD001364
p19
F0.001
sVCD001047
p20
F0.001
sV2607-18
p21
F0.001
sV750-758 9p
p22
F0.001
sV84301
p23
F0.001
sV348
p24
F0.001
sV22-Dec
p25
F0.001
sVe734-41
p26
F0.001
sV51-5
p27
F0.001
sV2425-31
p28
F0.001
sV256-62
p29
F0.001
sV261-4
p30
F0.001
sVE556-64
p31
F0.001
sV226-232
p32
F0.001
sVS40
p33
F0.001
sV431-446 16p
p34
F0.001
sV328-39
p35
F0.001
sV851-9
p36
F0.001
sV237-45
p37
F0.001
sV2.05427E+015
p38
F0.001
sV261-3
p39
F0.001
sV383-4
p40
F0.001
sV237-40
p41
F0.001
sV1232-40
p42
F0.001
sV237-48
p43
F0.001
sV3236-42 ST  - Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study-
p44
F0.001
sVS136
p45
F0.001
sV911-24
p46
F0.001
sV453-5, 459
p47
F0.001
sV1074-1077
p48
F0.001
sV1349-1353
p49
F0.001
sV146-51
p50
F0.001
sV240-6
p51
F0.001
sV204-9
p52
F0.001
sV373-378
p53
F0.001
sV2331-2337
p54
F0.001
sV194
p55
F0.001
sV715-727
p56
F0.001
sV291S-297S
p57
F0.001
sV1001-24
p58
F0.001
sV1257-66
p59
F0.001
sV146-152
p60
F0.001
sV202-11
p61
F0.001
sV1257-61
p62
F0.001
sV243-248
p63
F0.001
sV64-70
p64
F0.001
sV843-54
p65
F0.001
sV721-7
p66
F0.002
sVe70858
p67
F0.001
sV1050-1055
p68
F0.001
sV1518-25
p69
F0.001
sV68-74
p70
F0.001
sV2371-8
p71
F0.001
sV711-5
p72
F0.001
sV118-124 7p
p73
F0.001
sV526
p74
F0.001
sV295-301
p75
F0.001
sV391-406
p76
F0.001
sV774-9
p77
F0.001
sV331-338
p78
F0.001
sV286-91
p79
F0.001
sV138-52 ST  - The cost of depression-complicated alcoholism: health-care utilization and treatment effectiveness-
p80
F0.001
sV255-62
p81
F0.001
sV371-80; discussion 435-513
p82
F0.001
sV55-56
p83
F0.001
sV222-8
p84
F0.001
sV43-49
p85
F0.001
sV207-220
p86
F0.001
sV105
p87
F0.001
sVS67-8 1p
p88
F0.001
sV531-9
p89
F0.001
sV30-35
p90
F0.001
sV1943-1946
p91
F0.001
sV32
p92
F0.001
sV159-166
p93
F0.001
sV112-120
p94
F0.001
sV323-326
p95
F0.001
sV34
p96
F0.002
sV2496-502
p97
F0.001
sV1005-7
p98
F0.001
sV999-1004
p99
F0.001
sV383-92
p100
F0.001
sV13-29
p101
F0.001
sV384-8
p102
F0.001
sV39-44
p103
F0.001
sV1203-14
p104
F0.001
sV233-43; discussion 243
p105
F0.001
sV1531-7
p106
F0.001
sV605-9
p107
F0.001
sVA176
p108
F0.001
sV1796-7
p109
F0.001
sV974-7
p110
F0.001
sV2055-9
p111
F0.001
sV535-41
p112
F0.001
sV156-9
p113
F0.001
sV327-35
p114
F0.001
sV1681-7
p115
F0.001
sV172-82
p116
F0.001
sV1455-1462
p117
F0.001
sV80-96
p118
F0.001
sV314-320
p119
F0.001
sV297-310
p120
F0.001
sV409-414
p121
F0.001
sV185-90
p122
F0.002
sV462-70
p123
F0.001
sV15-16
p124
F0.001
sV27-32 ST  - Wound care-
p125
F0.001
sV158-61
p126
F0.001
sV1187-9
p127
F0.001
sV427-35
p128
F0.002
sV139-145
p129
F0.001
sV1061-5
p130
F0.001
sV241-242
p131
F0.001
sV319-324
p132
F0.001
sV599-606
p133
F0.001
sV4482-4486
p134
F0.001
sV601-7
p135
F0.001
sV40-43
p136
F0.001
sV361-368
p137
F0.001
sV19-24
p138
F0.001
sV392-398
p139
F0.001
sV700-4
p140
F0.001
sV131-134
p141
F0.002
sV131-137
p142
F0.001
sV139-43
p143
F0.001
sV382-7
p144
F0.001
sV693-6; discussion 697 ST  - Value of intravenous cholangiography prior to laparoscopic cholecystectomy-
p145
F0.001
sV983-6
p146
F0.001
sV1858-63
p147
F0.001
sV45-53; quiz 54
p148
F0.001
sV19th Congress of the European Hematology Association Milan Italy. Conference Start: 20140612 Conference End: 20140615. Conference Publication: (var.pagings). 99 (pp 233)
p149
F0.001
sV1127-33
p150
F0.001
sV152-6
p151
F0.001
sV359-362
p152
F0.001
sV152-5
p153
F0.001
sV69-74
p154
F0.001
sV1635-1643
p155
F0.001
sV152-9
p156
F0.001
sVS306-S314
p157
F0.001
sV103-119
p158
F0.001
sVS131-2
p159
F0.001
sV33501
p160
F0.001
sV182-195
p161
F0.001
sV454-460
p162
F0.001
sV230-232
p163
F0.001
sV769-86
p164
F0.001
sV870-5
p165
F0.001
sV1337-45
p166
F0.001
sV625-7
p167
F0.001
sV570-4
p168
F0.001
sV459-65
p169
F0.001
sV170-5
p170
F0.001
sV481-489
p171
F0.001
sV93-6
p172
F0.001
sV178-88
p173
F0.001
sV159-86
p174
F0.001
sV720-6
p175
F0.002
sV421-7
p176
F0.001
sV93-7
p177
F0.001
sV217-24
p178
F0.001
sV1078-87
p179
F0.001
sV327-32
p180
F0.002
sV28-Jul
p181
F0.001
sV2427-36
p182
F0.001
sV141-51
p183
F0.001
sV160-172
p184
F0.001
sV1039-46
p185
F0.001
sV143-156
p186
F0.001
sV1347-53 ST  - Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls-
p187
F0.001
sV636-45
p188
F0.001
sV733-748
p189
F0.001
sV141
p190
F0.001
sV94-95
p191
F0.001
sV733-743
p192
F0.001
sV393-411
p193
F0.001
sV177-91
p194
F0.001
sV479-82
p195
F0.001
sV2276-83
p196
F0.001
sV359-61
p197
F0.001
sV324-326
p198
F0.001
sV1035-46
p199
F0.001
sV378-84
p200
F0.002
sV780-98
p201
F0.001
sV584-90
p202
F0.001
sV30-33 ST  - No need for routine closed suction drainage in elective arthroplasty of the hip: a prospective randomized trial in 104 operations-
p203
F0.001
sV360-374
p204
F0.001
sVe213-8
p205
F0.001
sVB570-9
p206
F0.001
sV217-26
p207
F0.001
sV10213-10224
p208
F0.001
sV167-71
p209
F0.001
sV269-77
p210
F0.001
sV319-330
p211
F0.001
sV617-23
p212
F0.001
sV617-22
p213
F0.001
sV389-95
p214
F0.001
sV138-139
p215
F0.001
sV1128-31
p216
F0.001
sVS25-7
p217
F0.001
sV94-104
p218
F0.001
sV259-65
p219
F0.001
sV253-4
p220
F0.001
sV1468-74
p221
F0.001
sV8-16 ST  - Cardiac atrophy in women following bed rest-
p222
F0.001
sV6-Jan
p223
F0.001
sV83-88
p224
F0.001
sV139
p225
F0.001
sV591-5
p226
F0.001
sV976-9
p227
F0.001
sV25
p228
F0.002
sV20
p229
F0.001
sV451-457
p230
F0.001
sV173-181
p231
F0.001
sV233-44
p232
F0.001
sV685-90
p233
F0.001
sV603-11
p234
F0.001
sV1723-7
p235
F0.001
sV817-823
p236
F0.001
sV110-1
p237
F0.001
sV1541-7
p238
F0.001
sV110-6
p239
F0.001
sV275-287
p240
F0.001
sV785-794
p241
F0.001
sV156-61
p242
F0.001
sV984-98
p243
F0.001
sV234-249
p244
F0.001
sV840-54
p245
F0.001
sV2603-8
p246
F0.001
sV643-50 ST  - Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial-
p247
F0.001
sV581-91
p248
F0.001
sV182-91
p249
F0.001
sV151-158
p250
F0.001
sV26-Jan
p251
F0.001
sV550-64
p252
F0.001
sV145-8
p253
F0.001
sV119-126 8p
p254
F0.001
sV238-49
p255
F0.001
sV1112-6
p256
F0.001
sVe50836
p257
F0.001
sV74-6
p258
F0.001
sV969-75
p259
F0.001
sV153-6
p260
F0.001
sV341-51
p261
F0.001
sVW1-W4
p262
F0.001
sV290-5
p263
F0.001
sV60-61
p264
F0.001
sV823-830
p265
F0.001
sV1756-1764
p266
F0.001
sV706-17
p267
F0.001
sV919-21
p268
F0.001
sV15-Oct
p269
F0.001
sV100A
p270
F0.001
sV703
p271
F0.001
sV43-4
p272
F0.001
sV875-916
p273
F0.001
sV46-55
p274
F0.001
sV91-8
p275
F0.001
sV395
p276
F0.001
sV664-669
p277
F0.001
sV43-8
p278
F0.001
sV91-3
p279
F0.001
sVe867-98
p280
F0.001
sV20-6, 28
p281
F0.001
sV353-7
p282
F0.001
sV143-153
p283
F0.001
sVG11-G15
p284
F0.001
sV105-18
p285
F0.001
sV913-9
p286
F0.001
sV167-175
p287
F0.001
sV42-53
p288
F0.001
sV283-90
p289
F0.001
sV189-196
p290
F0.001
sVS149
p291
F0.001
sVi48-55
p292
F0.001
sV1255-1272
p293
F0.001
sVCD002843
p294
F0.001
sV432-438
p295
F0.001
sV159-63
p296
F0.001
sV2207-14
p297
F0.001
sVe1327-9
p298
F0.001
sV127-31 ST  - Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?-
p299
F0.001
sV144-56
p300
F0.001
sV454-60
p301
F0.001
sV29-32
p302
F0.001
sV527-33
p303
F0.001
sV3541-4
p304
F0.001
sV477-505
p305
F0.001
sV29-33
p306
F0.001
sV1419-25
p307
F0.001
sV190-1
p308
F0.001
sV193-9
p309
F0.001
sV34-41 ST  - Shedding health risks with bariatric weight loss surgery-
p310
F0.001
sV546-8
p311
F0.001
sV196-203
p312
F0.001
sV55-56 2p
p313
F0.001
sV49-55
p314
F0.001
sV23-31
p315
F0.001
sV52-63
p316
F0.001
sV2571
p317
F0.001
sV323-330
p318
F0.001
sV701-707
p319
F0.001
sVe92590
p320
F0.001
sV71-80
p321
F0.001
sV1309-1318
p322
F0.001
sV791-799
p323
F0.001
sV930-936
p324
F0.001
sV9-Mar
p325
F0.001
sV77-95
p326
F0.001
sVS10-3
p327
F0.001
sVw13728
p328
F0.001
sV447-52 ST  - [Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)]-
p329
F0.001
sV2049
p330
F0.001
sV53-62
p331
F0.001
sV413-27
p332
F0.001
sV254-262
p333
F0.001
sV121-36
p334
F0.001
sV35-40
p335
F0.001
sV348-357
p336
F0.001
sVe35061
p337
F0.001
sV231-5-
p338
F0.001
sV693-9
p339
F0.001
sV209-234
p340
F0.001
sV1972-4
p341
F0.001
sVA31
p342
F0.001
sV271-7
p343
F0.001
sV4-47-53
p344
F0.001
sV323-333
p345
F0.001
sV1433-41
p346
F0.001
sV7-Jan
p347
F0.002
sViii35-44
p348
F0.001
sV1126-1141
p349
F0.001
sVS398
p350
F0.001
sVe483; author's reply e484
p351
F0.001
sV305-310
p352
F0.001
sVe005077
p353
F0.001
sVS50-5
p354
F0.001
sVe005601
p355
F0.001
sV223-230
p356
F0.001
sV201-205
p357
F0.001
sV183-9
p358
F0.001
sV458-462
p359
F0.001
sV593-610
p360
F0.001
sV339-52
p361
F0.001
sV14-17
p362
F0.001
sV251-6
p363
F0.001
sV179-81
p364
F0.001
sV1777-86
p365
F0.001
sV609-21
p366
F0.001
sV13
p367
F0.001
sVeS502-eS503
p368
F0.001
sV17
p369
F0.001
sV650-4
p370
F0.001
sVZC70-5
p371
F0.001
sVCd006178
p372
F0.001
sV890-902
p373
F0.001
sVE315-6
p374
F0.001
sV520-3
p375
F0.001
sV545-9
p376
F0.001
sV590-6
p377
F0.001
sV731-741
p378
F0.001
sV593-5
p379
F0.001
sV1928-33
p380
F0.001
sV17-8
p381
F0.001
sV24-32
p382
F0.001
sV105-109
p383
F0.001
sV629-30
p384
F0.001
sVS32-47
p385
F0.001
sV79-85
p386
F0.001
sV577-588
p387
F0.001
sV79-80
p388
F0.001
sV41-7
p389
F0.001
sV94-9
p390
F0.001
sV247-256 10p
p391
F0.001
sVe112077
p392
F0.001
sV639-49
p393
F0.001
sV1108-18
p394
F0.001
sV524-529
p395
F0.001
sV1763-9
p396
F0.001
sV-
p397
F0.002
sV842-848
p398
F0.001
sV106-119
p399
F0.001
sV186-192
p400
F0.001
sV93-99 7p
p401
F0.001
sV1947-1963
p402
F0.001
sV104-7; discussion 108
p403
F0.001
sV328
p404
F0.001
sV260-87
p405
F0.001
sV277-286
p406
F0.001
sV513-6
p407
F0.001
sV625-31
p408
F0.001
sV362-9
p409
F0.001
sV190-192
p410
F0.001
sV265-72
p411
F0.001
sV502-8
p412
F0.001
sV75
p413
F0.001
sV212-8
p414
F0.001
sV20120261
p415
F0.001
sV5-Feb
p416
F0.001
sV3196-3199
p417
F0.001
sV544-55
p418
F0.001
sV584-92
p419
F0.001
sVe1001835; discussion e1001835-e1001835; discussion e1001835
p420
F0.001
sV422-424
p421
F0.001
sV21-24
p422
F0.001
sV153-163
p423
F0.002
sV221-32
p424
F0.001
sV123-6
p425
F0.001
sV447-52
p426
F0.002
sV447-55
p427
F0.001
sV1296-304
p428
F0.001
sV1883-94
p429
F0.001
sV708-711
p430
F0.001
sV18-30
p431
F0.001
sV708-715
p432
F0.001
sV2211-22
p433
F0.001
sV68-75
p434
F0.001
sV131-4
p435
F0.001
sV25-29
p436
F0.001
sV607-10
p437
F0.001
sV25-26
p438
F0.001
sV1219-1220
p439
F0.001
sVP435
p440
F0.001
sV135-144
p441
F0.001
sV715-721
p442
F0.001
sVe75079
p443
F0.001
sV87-95; discussion 95-6
p444
F0.001
sV3535-44
p445
F0.001
sV484-7
p446
F0.001
sV373-6
p447
F0.001
sV255-63
p448
F0.001
sV18-Nov
p449
F0.001
sV2018-2020
p450
F0.001
sV56-60
p451
F0.001
sV390-8
p452
F0.001
sV791-802
p453
F0.001
sV56-64
p454
F0.001
sV615-622 8p
p455
F0.001
sViii25-iii25
p456
F0.001
sV96-160
p457
F0.001
sV51-54 4p
p458
F0.001
sV8
p459
F0.001
sV1487-90
p460
F0.001
sV209-19
p461
F0.001
sV62928
p462
F0.001
sV209-14
p463
F0.001
sV251-264
p464
F0.001
sV815-22
p465
F0.001
sV398-407
p466
F0.001
sV20-4 ST  - Preferences and practices of Americans and their physicians in antihypertensive therapy-
p467
F0.001
sV1114-7 ST  - A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain-
p468
F0.001
sV364-71
p469
F0.001
sV65-68-
p470
F0.001
sV149-156
p471
F0.001
sV259-64
p472
F0.001
sV725.e11-5
p473
F0.001
sV627-30
p474
F0.001
sV714-22
p475
F0.001
sV562-569
p476
F0.001
sV550-561
p477
F0.001
sV1530-9
p478
F0.001
sV374-8
p479
F0.001
sV81-90
p480
F0.001
sV419
p481
F0.001
sV527-35
p482
F0.001
sV99-106
p483
F0.001
sV1427-30
p484
F0.001
sV2761-2769 9p
p485
F0.001
sV1164-1173 DO  - 10.1002/cncr.11174
p486
F0.001
sV13-21 DO  - 10.1016/j.brat.2011.10.009
p487
F0.001
sV1171-1178
p488
F0.001
sV542-549
p489
F0.001
sV204-16
p490
F0.001
sV917-920
p491
F0.001
sV465-6
p492
F0.001
sV257-8
p493
F0.001
sV11-Sep
p494
F0.001
sV9-Jun
p495
F0.001
sV22-34
p496
F0.001
sV1945-52
p497
F0.001
sV120 [TP 184]
p498
F0.001
sV1261-9 ST  - Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders-
p499
F0.001
sV1331-4
p500
F0.001
sV440-4
p501
F0.001
sV3017-28
p502
F0.001
sV461-7
p503
F0.001
sVe7
p504
F0.001
sV441-55
p505
F0.001
sV435-441
p506
F0.001
sV435-442
p507
F0.001
sVCd001799
p508
F0.001
sVS331-
p509
F0.001
sV64-7
p510
F0.001
sV248-54
p511
F0.001
sV142-166
p512
F0.001
sV736-44
p513
F0.001
sV248-58
p514
F0.001
sV307-17
p515
F0.001
sV195-202
p516
F0.001
sV925-31
p517
F0.001
sV507-18
p518
F0.001
sV368-72
p519
F0.001
sV273-6
p520
F0.001
sV163-176
p521
F0.001
sV1605-11
p522
F0.001
sV13-May
p523
F0.001
sV1556-1579
p524
F0.001
sV208-213
p525
F0.001
sV22
p526
F0.002
sV288-94
p527
F0.001
sV1237-48
p528
F0.001
sV392-7 ST  - [Dinggui Oil Capsule in treating irritable bowel syndrome with stagnation of qi and cold: a prospective, multi-center, randomized, placebo-controlled, double-blind trial]-
p529
F0.001
sV207-13
p530
F0.001
sV1228-37
p531
F0.001
sV214-8
p532
F0.001
sV1892-900
p533
F0.001
sViii-vii
p534
F0.001
sV26-39
p535
F0.001
sV471-3
p536
F0.001
sV471-6
p537
F0.001
sV83-7
p538
F0.001
sV759-63
p539
F0.001
sV759-60
p540
F0.001
sV756-60
p541
F0.001
sV159-73
p542
F0.001
sV2063-8
p543
F0.001
sV50-55
p544
F0.001
sVe249-
p545
F0.001
sV2700-7
p546
F0.001
sV714-9 ST  - [Noninvasive prenatal diagnosis of trisomy 21, 18 and 13 using cell-free fetal DNA]-
p547
F0.001
sV922-9
p548
F0.001
sV612-7
p549
F0.001
sV84-8
p550
F0.001
sV119-125 7p
p551
F0.001
sV343-51
p552
F0.001
sV400-405
p553
F0.001
sV281-5
p554
F0.001
sV615-9
p555
F0.001
sVS13
p556
F0.001
sV615-7
p557
F0.001
sV1270-7
p558
F0.001
sV2692-9
p559
F0.001
sV469-75
p560
F0.001
sVB123-6
p561
F0.001
sV544-7 ST  - Recurrent distal 16q duplication and terminal 22q deletion: prenatal diagnosis and genetic counseling-
p562
F0.001
sV733
p563
F0.001
sV603-10
p564
F0.001
sV283-296
p565
F0.001
sV6-Oct
p566
F0.001
sV1145-53
p567
F0.001
sV437-41
p568
F0.001
sV231-47
p569
F0.001
sV437-42
p570
F0.001
sV3118-29
p571
F0.001
sV633-58 ST  - Prebiotics, immune function, infection and inflammation: a review of the evidence-
p572
F0.001
sV187-93
p573
F0.001
sV841-7
p574
F0.001
sV287-291
p575
F0.001
sV98--100
p576
F0.001
sV53-58
p577
F0.001
sV74570A-74570A-9
p578
F0.001
sV646-666
p579
F0.001
sV141-8
p580
F0.001
sVe109114
p581
F0.001
sV2562-9 ST  - Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome-
p582
F0.001
sV381-386
p583
F0.001
sV375-93
p584
F0.001
sV525-531 ST  - How to appraise the effectiveness of treatment-
p585
F0.001
sV135-41
p586
F0.001
sVA776
p587
F0.001
sV331-373
p588
F0.001
sV47-51 ST  - The concept of neurosis in a cross-cultural perspective-
p589
F0.001
sV141-149
p590
F0.001
sV3582-9
p591
F0.001
sVe103065
p592
F0.001
sV262-265 ST  - Poster abstracts. The National Association of Bariatric Nurses, 4th Annual Meeting and Conference, October 24-27, 2007, North Charleston, South Carolina-
p593
F0.001
sV185-91
p594
F0.001
sV289-318
p595
F0.001
sV113
p596
F0.001
sV36
p597
F0.001
sV987149
p598
F0.001
sV74-82
p599
F0.001
sV1727-33
p600
F0.001
sV827-836
p601
F0.001
sV130-48
p602
F0.001
sV10-May
p603
F0.001
sV366-74
p604
F0.001
sV408-427
p605
F0.001
sV11342-11352
p606
F0.001
sV449-+
p607
F0.001
sV415-422 8p
p608
F0.001
sV134-44
p609
F0.001
sV166-188
p610
F0.001
sV559-62
p611
F0.001
sV414-6
p612
F0.001
sV1323-30
p613
F0.001
sV48-57; quiz 58, 60
p614
F0.001
sV78-83
p615
F0.001
sV1652-8
p616
F0.001
sV1295-1305
p617
F0.001
sV1173-8
p618
F0.001
sV791-9
p619
F0.001
sV1652-6
p620
F0.001
sV336-49
p621
F0.001
sV144-147
p622
F0.002
sV130-2
p623
F0.001
sV36-42
p624
F0.001
sV29-38
p625
F0.001
sV81-3
p626
F0.001
sV435-40
p627
F0.001
sV207-20
p628
F0.001
sV314-21
p629
F0.001
sV316-26; discussion 326-7
p630
F0.001
sVCd004797
p631
F0.001
sV347-55
p632
F0.001
sV572-84
p633
F0.001
sVA326
p634
F0.001
sV489-93
p635
F0.001
sV163-7
p636
F0.001
sV574-84
p637
F0.001
sV36-9
p638
F0.001
sV574-80
p639
F0.001
sV283-4
p640
F0.001
sV18-31 14p
p641
F0.001
sV3224
p642
F0.001
sV261-270 ST  - Are stretches effective in the prevention and treatment of glenohumeral internal rotation deficit?-
p643
F0.001
sV300-306
p644
F0.001
sV2826-34
p645
F0.001
sV1282-9
p646
F0.001
sV16-Mar
p647
F0.001
sV350
p648
F0.001
sVviii284
p649
F0.001
sV3191-7
p650
F0.001
sV245-8
p651
F0.001
sV100-4
p652
F0.001
sV291-297
p653
F0.001
sV574-578
p654
F0.001
sV316272
p655
F0.001
sV1074-9
p656
F0.001
sV113-129
p657
F0.001
sVS223
p658
F0.001
sV495-503
p659
F0.001
sV766-71
p660
F0.001
sV431-438
p661
F0.001
sV277-80
p662
F0.001
sV411-3
p663
F0.001
sV195-201
p664
F0.001
sV195-203
p665
F0.002
sV305-11
p666
F0.002
sV464-468
p667
F0.001
sV203-277
p668
F0.001
sV1271-6
p669
F0.001
sV695-702
p670
F0.001
sV13-14
p671
F0.001
sV421-6, 435, 434
p672
F0.001
sV632-9
p673
F0.001
sV63-66
p674
F0.001
sV20-20
p675
F0.001
sV631-8
p676
F0.001
sV3-Mar
p677
F0.001
sV13-21
p678
F0.001
sV2335-2340
p679
F0.001
sV556-65
p680
F0.001
sV10-Oct
p681
F0.001
sV1937-1958
p682
F0.001
sV25-33
p683
F0.001
sV663-695
p684
F0.001
sV146-160
p685
F0.001
sV336-48
p686
F0.001
sV124-31
p687
F0.001
sV223-38
p688
F0.001
sV728-730-
p689
F0.001
sVSP26-7
p690
F0.001
sV694-702
p691
F0.001
sV950-959
p692
F0.001
sV875-81
p693
F0.001
sV900-14
p694
F0.001
sV58
p695
F0.001
sV449-457
p696
F0.001
sV185-185
p697
F0.001
sV58-68 ST  - Exercise-induced changes of the upper extremity in chronic stroke survivors-
p698
F0.001
sV332-3
p699
F0.001
sV53
p700
F0.001
sV310-5
p701
F0.001
sV4327-4335
p702
F0.001
sV1556-9
p703
F0.001
sV2755-72
p704
F0.001
sV1017-28
p705
F0.001
sV143-9
p706
F0.001
sV66
p707
F0.001
sV667-77
p708
F0.001
sV79-105
p709
F0.001
sV493-503
p710
F0.001
sV551-561 ST  - Scar Management Practice and Science: A Comprehensive Approach to Controlling Scar Tissue and Avoiding Hypertrophic Scarring.... Reprinted and adapted with permission from Wound Healing South Africa and Medpharm. Widgerow AD. Scar management
p711
F0.001
sV33-43
p712
F0.001
sV207-212
p713
F0.001
sV514-27
p714
F0.001
sV310-4
p715
F0.001
sV225-263
p716
F0.001
sV798-805
p717
F0.001
sV1140-50
p718
F0.001
sV274-82
p719
F0.001
sV1159-73
p720
F0.001
sV2777-85
p721
F0.001
sV613-5
p722
F0.001
sV1245-50
p723
F0.001
sV642-55
p724
F0.001
sV320-6
p725
F0.001
sV1442-6
p726
F0.001
sV1925-1929
p727
F0.001
sV6-May
p728
F0.001
sV179-186
p729
F0.001
sV119-125
p730
F0.001
sV39-51
p731
F0.001
sV3111-9
p732
F0.001
sV1158-78
p733
F0.001
sV19-35
p734
F0.001
sV453-60
p735
F0.001
sV673-692
p736
F0.001
sV2815-7
p737
F0.001
sV68-9 ST  - The cost of national service frameworks-
p738
F0.001
sV161-5
p739
F0.001
sV589-96
p740
F0.001
sV322-9
p741
F0.001
sV22-25
p742
F0.001
sVf5001
p743
F0.001
sV1241; author reply 1241
p744
F0.001
sV297-301
p745
F0.001
sV745-50
p746
F0.001
sV384-6 ST  - Proximal migration of a 5 French pancreatic stent during bile stone extraction: a successful retrieval using mini-snare-
p747
F0.001
sV317-325
p748
F0.001
sV677-680
p749
F0.001
sV1-Jan
p750
F0.001
sV167-72
p751
F0.001
sV974-81
p752
F0.001
sV72
p753
F0.001
sV71-7
p754
F0.001
sV101-108
p755
F0.001
sV134-9
p756
F0.001
sV15-Jan
p757
F0.001
sV1304-16
p758
F0.001
sV11-Jan
p759
F0.001
sV390-3
p760
F0.001
sV813-20
p761
F0.001
sV160-6
p762
F0.001
sV419-21
p763
F0.001
sV31-40
p764
F0.001
sV38-41
p765
F0.001
sV227-33
p766
F0.001
sV298-308
p767
F0.001
sV47-55
p768
F0.001
sV57-64
p769
F0.001
sV57-65
p770
F0.001
sV202-208
p771
F0.001
sV57-61
p772
F0.002
sVS46-S61
p773
F0.001
sV597-605
p774
F0.001
sV597-601
p775
F0.001
sV639-46
p776
F0.001
sV425.e1-6
p777
F0.001
sV391-398
p778
F0.001
sV149-57
p779
F0.001
sV265-9
p780
F0.001
sV346-352
p781
F0.002
sV616-626
p782
F0.001
sV14306-14311
p783
F0.001
sV135-138
p784
F0.001
sV1182-7
p785
F0.001
sV125-142
p786
F0.001
sV446-55
p787
F0.001
sV446-53
p788
F0.001
sV227
p789
F0.001
sV240-54
p790
F0.001
sV729-35
p791
F0.001
sV4086-93
p792
F0.001
sV244-233
p793
F0.001
sV449-455
p794
F0.001
sV343-7
p795
F0.001
sVS29-36
p796
F0.001
sV1325-1332
p797
F0.001
sV330-7
p798
F0.001
sV326-327
p799
F0.001
sV299-314
p800
F0.001
sV410-413
p801
F0.001
sV63-71 ST  - Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?-
p802
F0.001
sVCD001880
p803
F0.001
sVe1919
p804
F0.001
sV184-9 ST  - Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome-
p805
F0.001
sV721
p806
F0.001
sVS156-S157
p807
F0.001
sV945-52
p808
F0.001
sV27386-99
p809
F0.001
sV153
p810
F0.001
sV251-257
p811
F0.001
sV58-69
p812
F0.002
sV545-53
p813
F0.001
sV1343S-1353S
p814
F0.001
sV2024; author reply 2026-7
p815
F0.001
sV468-493
p816
F0.001
sV18-24
p817
F0.001
sV923129
p818
F0.001
sV529-33
p819
F0.001
sV55-60
p820
F0.001
sV177-88
p821
F0.001
sV833-9
p822
F0.001
sV923-931
p823
F0.001
sV834-40
p824
F0.001
sV54-62
p825
F0.001
sV89-101
p826
F0.001
sV130-4
p827
F0.001
sV655-663
p828
F0.001
sV46
p829
F0.001
sV565-9
p830
F0.001
sV238
p831
F0.001
sV488-96
p832
F0.001
sV1444
p833
F0.001
sV991-5
p834
F0.001
sV7111-7120
p835
F0.001
sV361-5
p836
F0.001
sV361-3
p837
F0.001
sV112-7
p838
F0.001
sV1147-60
p839
F0.001
sV3917-31
p840
F0.001
sV120-6 ST  - Bioavailability and tolerability of intranasal diazepam in healthy adult volunteers-
p841
F0.001
sVe004623
p842
F0.001
sV477-83
p843
F0.001
sV2752-63
p844
F0.001
sV1314-21
p845
F0.001
sV112-8
p846
F0.001
sV9-Jan
p847
F0.001
sV835-42
p848
F0.001
sV835-40
p849
F0.002
sV862-869
p850
F0.001
sV119-26
p851
F0.001
sV239-46
p852
F0.001
sV512-9 ST  - A performance improvement process to tackle tachysystole-
p853
F0.001
sV341-6
p854
F0.001
sV341-7
p855
F0.001
sV223-7
p856
F0.001
sV889-94
p857
F0.001
sV1068-1074
p858
F0.001
sV655-661
p859
F0.001
sV81-83
p860
F0.001
sV257-264
p861
F0.001
sV5635-42
p862
F0.001
sV37-41 DO  - 10.1080/10810730902805788
p863
F0.001
sV1704-10 ST  - Aerobic fitness testing in patients with chronic low back pain: which test is best?-
p864
F0.001
sV266-8
p865
F0.001
sV10-14 DO  - 10.1016/S0748-7983(10)00156-3
p866
F0.001
sV315-20
p867
F0.001
sV59-63
p868
F0.001
sV15-20
p869
F0.001
sV15-21
p870
F0.001
sV15-22
p871
F0.001
sV66-76
p872
F0.001
sV1307-12
p873
F0.001
sVP3021
p874
F0.001
ssS'characters'
p875
(dp876
V 
p877
F0.068
sV'
p878
F0.002
sV)
p879
F0.005
sV(
p880
F0.005
sV+
p881
F0.002
sg397
F0.805
sV,
p882
F0.012
sV/
p883
F0.004
sV.
p884
F0.011
sV1
p885
F0.48
sV0
p886
F0.271
sV3
p887
F0.401
sV2
p888
F0.393
sV5
p889
F0.357
sV4
p890
F0.354
sV7
p891
F0.321
sV6
p892
F0.316
sV9
p893
F0.287
sg459
F0.252
sV;
p894
F0.012
sV:
p895
F0.012
sV?
p896
F0.004
sVA
p897
F0.016
sVC
p898
F0.018
sVB
p899
F0.004
sVE
p900
F0.005
sVD
p901
F0.013
sVG
p902
F0.001
sVF
p903
F0.002
sVI
p904
F0.001
sVH
p905
F0.005
sVJ
p906
F0.01
sVM
p907
F0.012
sVO
p908
F0.01
sVN
p909
F0.004
sVP
p910
F0.013
sVS
p911
F0.057
sVR
p912
F0.004
sVT
p913
F0.034
sVW
p914
F0.003
sVV
p915
F0.001
sV[
p916
F0.004
sVZ
p917
F0.002
sV]
p918
F0.004
sVa
p919
F0.052
sVc
p920
F0.043
sVb
p921
F0.017
sVe
p922
F0.062
sVd
p923
F0.037
sVg
p924
F0.022
sVf
p925
F0.031
sVi
p926
F0.045
sVh
p927
F0.032
sVk
p928
F0.008
sVj
p929
F0.001
sVm
p930
F0.029
sVl
p931
F0.034
sVo
p932
F0.044
sVn
p933
F0.049
sVq
p934
F0.005
sVp
p935
F0.046
sVs
p936
F0.04
sVr
p937
F0.042
sVu
p938
F0.039
sVt
p939
F0.04
sVw
p940
F0.016
sVv
p941
F0.025
sVy
p942
F0.028
sVx
p943
F0.005
sVz
p944
F0.01
ss.